Life Spine Announces Over 20,000 Units Sold of the PROLIFT® Expandable System

January 5, 2020

HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company has sold over 20,000 PROLIFT Expandable Implants.

“Expandable technology is on track to make up almost half of the domestic interbody market in the next five years1 and we pride ourselves on having some of the oldest and broadest intellectual property encapsulating expandable spine technology,” said Michael Butler, President and CEO of Life Spine. “The rapid adoption of our Micro Invasive expandable portfolio is a direct result of our commitment to constantly innovate and create products designed to optimize spine surgery.”

“The PROLIFT Expandable Interbody is my preferred lumbar interbody for myriad reasons,” said Dr. Hajeer Sabet of Woodbridge, VA. “The implant can achieve up to 6mm of expansion, is self-locking at any height and can be post-packed in situ. Additionally, it is available in a large number of footprints to accommodate varying patient anatomies and features a proprietary surface technology.”

About Life Spine

Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit: http://www.lifespine.com and/or https://www.micro-invasive.com.

1iData. (2019) US Market Report Suite for Spinal Implants and VCF


Mr. Omar Faruqi
Chief Financial Officer

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button